
Robert J. May
Examiner (ID: 11356, Phone: (571)272-5919 , Office: P/2875 )
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2875, 2885 |
| Total Applications | 1496 |
| Issued Applications | 1117 |
| Pending Applications | 52 |
| Abandoned Applications | 358 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10406952
[patent_doc_number] => 20150291961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 14/743764
[patent_app_country] => US
[patent_app_date] => 2015-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14644
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14743764
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/743764 | RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX | Jun 17, 2015 | Abandoned |
Array
(
[id] => 10653910
[patent_doc_number] => 20160000054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'HUMAN-DERIVED MUTANTS OF THE dSOD1 GENE IN DROSOPHILA AND METHODS OF MAKING AND USING'
[patent_app_type] => utility
[patent_app_number] => 14/741534
[patent_app_country] => US
[patent_app_date] => 2015-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11435
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14741534
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/741534 | HUMAN-DERIVED MUTANTS OF THE dSOD1 GENE IN DROSOPHILA AND METHODS OF MAKING AND USING | Jun 16, 2015 | Abandoned |
Array
(
[id] => 10401768
[patent_doc_number] => 20150286777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'Inhibition of Fibrosis and AF By TGF-Beta Inhibition in the Posterior Left Atrium (PLA)'
[patent_app_type] => utility
[patent_app_number] => 14/739374
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11462
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739374
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/739374 | Inhibition of Fibrosis and AF By TGF-Beta Inhibition in the Posterior Left Atrium (PLA) | Jun 14, 2015 | Abandoned |
Array
(
[id] => 11602389
[patent_doc_number] => 20170119688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'Disintegratable Core/Shell Silica Particles for Encapsulating and Releasing Bioactive Macromolecules'
[patent_app_type] => utility
[patent_app_number] => 15/318189
[patent_app_country] => US
[patent_app_date] => 2015-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17207
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15318189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/318189 | Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules | Jun 11, 2015 | Issued |
Array
(
[id] => 11821844
[patent_doc_number] => 20170210781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'POLYPEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/316458
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8788
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316458
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316458 | POLYPEPTIDES AND USES THEREOF | Jun 4, 2015 | Abandoned |
Array
(
[id] => 11715160
[patent_doc_number] => 20170183660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'APTAMER TARGETING MAGE-A3 PEPTIDE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/312667
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9632
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312667
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312667 | Aptamer targeting MAGE-A3 peptide and uses thereof | May 28, 2015 | Issued |
Array
(
[id] => 10457150
[patent_doc_number] => 20150342165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'HUMANIZED MOUSE AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/722326
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15203
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722326
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/722326 | HUMANIZED MOUSE AND METHODS OF USING THE SAME | May 26, 2015 | Abandoned |
Array
(
[id] => 11850280
[patent_doc_number] => 20170224772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'COMPOSITION AND KIT FOR PREVENTION OR TREATMENT OF ARTHRITIS, AND METHOD USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/313734
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7134
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313734
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313734 | COMPOSITION AND KIT FOR PREVENTION OR TREATMENT OF ARTHRITIS, AND METHOD USING THE SAME | May 25, 2015 | Abandoned |
Array
(
[id] => 10365833
[patent_doc_number] => 20150250838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Oncolytic Measles Virus'
[patent_app_type] => utility
[patent_app_number] => 14/719906
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 79
[patent_no_of_words] => 12530
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719906
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/719906 | Oncolytic measles virus | May 21, 2015 | Issued |
Array
(
[id] => 11706643
[patent_doc_number] => 20170175143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'METHOD FOR EDITING A GENETIC SEQUENCE'
[patent_app_type] => utility
[patent_app_number] => 15/311685
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12931
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311685
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/311685 | METHOD FOR EDITING A GENETIC SEQUENCE | May 19, 2015 | Abandoned |
Array
(
[id] => 16564462
[patent_doc_number] => 10889823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Bacteria-based protein delivery
[patent_app_type] => utility
[patent_app_number] => 15/311424
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 24987
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311424
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/311424 | Bacteria-based protein delivery | May 19, 2015 | Issued |
Array
(
[id] => 10353521
[patent_doc_number] => 20150238526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/707654
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18200
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707654
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707654 | CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS | May 7, 2015 | Abandoned |
Array
(
[id] => 10790051
[patent_doc_number] => 20160136207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/707739
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18203
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707739
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707739 | CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS | May 7, 2015 | Abandoned |
Array
(
[id] => 10353536
[patent_doc_number] => 20150238541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/707872
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18199
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707872
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707872 | CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS | May 7, 2015 | Abandoned |
Array
(
[id] => 10676642
[patent_doc_number] => 20160022786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'Anti-Cancer Combination Treatment and Kit-of-Parts'
[patent_app_type] => utility
[patent_app_number] => 14/705346
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 76162
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14705346
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/705346 | Anti-Cancer Combination Treatment and Kit-of-Parts | May 5, 2015 | Abandoned |
Array
(
[id] => 14360165
[patent_doc_number] => 10301370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Compositions and methods of chimeric autoantibody receptor T cells
[patent_app_type] => utility
[patent_app_number] => 15/307644
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 45
[patent_no_of_words] => 24101
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307644
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/307644 | Compositions and methods of chimeric autoantibody receptor T cells | Apr 30, 2015 | Issued |
Array
(
[id] => 10574180
[patent_doc_number] => 09296807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-29
[patent_title] => 'Method for expression of specific gene'
[patent_app_type] => utility
[patent_app_number] => 14/701929
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 13516
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701929
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/701929 | Method for expression of specific gene | Apr 30, 2015 | Issued |
Array
(
[id] => 11436409
[patent_doc_number] => 20170037431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'In vivo Gene Engineering with Adenoviral Vectors'
[patent_app_type] => utility
[patent_app_number] => 15/305300
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 21753
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305300 | In vivo Gene Engineering with Adenoviral Vectors | Apr 30, 2015 | Abandoned |
Array
(
[id] => 11457116
[patent_doc_number] => 20170051022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'ADENOVIRUS COMPRISING AN ALBUMIN-BINDING MOIETY'
[patent_app_type] => utility
[patent_app_number] => 15/307408
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17870
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307408
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/307408 | Adenovirus comprising an albumin-binding moiety | Apr 29, 2015 | Issued |
Array
(
[id] => 16141993
[patent_doc_number] => 10704061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Lentiviral vectors
[patent_app_type] => utility
[patent_app_number] => 15/312026
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 28
[patent_no_of_words] => 25260
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312026
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312026 | Lentiviral vectors | Apr 22, 2015 | Issued |